tiprankstipranks
Alpine Immune Sciences Inc (ALPN)
NASDAQ:ALPN
Holding ALPN?
Track your performance easily

Alpine Immune Sciences (ALPN) Ownership - Who Owns Alpine Immune Sciences?

446 Followers

Recent Insider Trading Activity

Date
Name
Activity
Value
May 10, 2024
Stanford L Peng
President & Head Of Research And Development
xxxxxxxxxxxxx
$669403
May 10, 2024
Mitchell Gold
Executive Chairman And Ceo,director
xxxxxxxxxxxxx
$100000
May 10, 2024
xxxxxxxxxxxxx
$513869
May 10, 2024
xxxxxxxxxxxxx
$275437

Recent Hedge Fund Trading Activity

Top Shareholders

Holder
# of Shares
Type
% Holding
Value

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,549,209Institution8.33%100,063,409
671,837Institution3.61%43,393,952
144,582Institution0.78%9,338,551
109,362Institution0.59%7,063,692
41,411Institution0.22%2,673,494
18,351Institution0.10%1,185,291
12,450Institution0.07%804,146
4,815Institution0.03%258,290
2,667Institution0.01%172,262
5,397Institution0.03%38,912

FAQ

Who Owns Alpine Immune Sciences Inc (ALPN)?
Currently, no data Available
What percentage of Alpine Immune Sciences Inc (ALPN) stock is held by institutional investors?
Currently, no data Available
What percentage of Alpine Immune Sciences Inc (ALPN) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Alpine Immune Sciences Inc (ALPN)?
Currently, no data Available
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
    What am I Missing?
    Make informed decisions based on Top Analysts' activity
    Know what industry insiders are buying
    Get actionable alerts from top Wall Street Analysts
    Find out before anyone else which stock is going to shoot up
    Get powerful stock screeners & detailed portfolio analysis